A CYP3A7 metabolically competent human induced pluripotent stem cell-derived hepatocyte-like cell (hHLC3A7) model for drug safety assessment in the newborn
Drug Metab Dispos. 2026 Apr 30;54(6):100314. doi: 10.1016/j.dmd.2026.100314. Online ahead of print. ABSTRACT Drug safety assessment in newborns is limited by ethical constraints and the… Read More »A CYP3A7 metabolically competent human induced pluripotent stem cell-derived hepatocyte-like cell (hHLC3A7) model for drug safety assessment in the newborn
